Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases [NA]
A pilot trial evaluating focal ablative stereotactic radiotherapy for cancers of the kidney and isolated adrenal metastases has completed.
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: Renal Hypothermia During Partial Nephrectomy [NA]
This entry reports a clinical trial on renal hypothermia during partial nephrectomy, sponsored by Ottawa Hospital Research Institute; the cu…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma [Phase 1]
A Phase 1 trial evaluating hydroxychloroquine administered before surgery in patients with renal cell carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma
A completed clinical trial update evaluates the optimal duration of tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
-
CLINICAL_TRIALS withdrawal · 2016-10-19Clinical Trial Update: Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma [Phase 3]
A Phase 3 trial of bevacizumab (rhuMAb VEGF) for metastatic renal cell carcinoma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-10-12FDA Approved: ZORTRESS — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for ZORTRESS (everolimus) submitted by Novartis Pharmaceuticals Corporation. The action likely a…
-
CLINICAL_TRIALS research · 2016-10-05Clinical Trial Update: Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage [NA]
Clinical trial update describing robot-assisted laparoscopic radiofrequency ablation–assisted enucleation for T1a renal cell carcinoma, with…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma [Phase 1]
Phase 1 study evaluating the combination of bevacizumab with buparlisib (BKM-120) in patients with metastatic renal cell carcinoma has compl…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating sorafenib with or without recombinant interferon alfa-2b in patients with metastatic renal cell carcinoma; results …
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating combinations of D-CIK immunotherapy with anti-PD-1 therapy in refractory solid tumors, including hepatoce…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy [NA]
A completed clinical trial evaluating whether ulinastatin improves postoperative renal function in patients undergoing robot-assisted laparo…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus [Phase 2]
This Phase 2 trial examined biomarkers before and after nephrectomy in patients with locally advanced or metastatic renal cell carcinoma tre…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy [Phase 2]
A Phase 2 trial comparing GDC-0980 with Everolimus in patients with metastatic renal cell carcinoma who progressed after VEGF-targeted thera…
-
CLINICAL_TRIALS research · 2016-07-29Clinical Trial Update: Transperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial Nephrectomy [NA]
This clinical trial compares transperitoneal versus retroperitoneal laparoscopic or robotic partial nephrectomy for renal cell carcinoma; cu…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma [NA]
The clinical trial evaluating neo-adjuvant temsirolimus in patients with advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS withdrawal · 2016-07-27Clinical Trial Update: Zero Ischemia Laparoscopic Partial Nephrectomy [Phase 2, Phase 3]
Clinical trial update for zero ischemia laparoscopic partial nephrectomy (Phase 2/3) with status withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-27Clinical Trial Update: Cryoablation Versus Radiofrequency Ablation for Small Renal Masses [Phase 2]
Phase 2 clinical trial comparing cryoablation and radiofrequency ablation for small renal masses has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating matched unrelated donor transplant for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer [Phase 2]
Phase 2 trial evaluating 5-fluorouracil followed by interferon-alfa-2b in previously treated patients with metastatic gastrointestinal cance…
-
EMA approval · 2016-07-22Two new medicines for advanced kidney cancer
The EMA announced two new medicines approved for advanced kidney cancer, expanding treatment options for this disease.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer
The document provides an update on a terminated clinical trial evaluating quality of life, fatigue, and cognitive function in anti-angiogeni…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial of capecitabine and gemcitabine in metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Bevacizumab in Metastatic Renal Cancer
A clinical trial evaluating bevacizumab in metastatic renal cell carcinoma has completed, and the results were posted in July 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) [Phase 3]
Phase 3 trial evaluating interferon alfa-2b with or without bevacizumab in advanced renal cell carcinoma has completed.